imfinzi
astrazeneca ab - durvalumab - krabbamein, lungnakrabbamein - Æxlishemjandi lyf - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).
aprepitant stada hart hylki 125 mg/80 mg
stada arzneimittel ag - aprepitantum inn - hart hylki - 125 mg/80 mg
holoxan innrennslisstofn, lausn 500 mg
baxter medical ab* - ifosfamidum inn - innrennslisstofn, lausn - 500 mg
holoxan innrennslisstofn, lausn 2000 mg
baxter medical ab* - ifosfamidum inn - innrennslisstofn, lausn - 2000 mg
holoxan innrennslisstofn, lausn 1000 mg
baxter medical ab* - ifosfamidum inn - innrennslisstofn, lausn - 1000 mg
ondansetron stada filmuhúðuð tafla 8 mg
stada arzneimittel ag - ondansetronum hýdróklóríð - filmuhúðuð tafla - 8 mg
flúoróúracil accord stungulyf/innrennslislyf, lausn 50 mg/ml
accord healthcare b.v. - fluorouracilum inn - stungulyf/innrennslislyf, lausn - 50 mg/ml
aprepitant medical valley hart hylki 125 mg + 80 mg
medical valley invest ab - aprepitantum inn - hart hylki - 125 mg + 80 mg
methotrexate pfizer (methotrexate wyeth) tafla 2,5 mg
pfizer aps - methotrexatum inn - tafla - 2,5 mg
conoxia lyfjagas, fljótandi 100 %
linde gas - oxygenium - lyfjagas, fljótandi - 100 %